Type 2 diabetes hypoglycaemia risk — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyEndocrine TherapeuticsType 2 diabetes hypoglycaemia riskGPhC CRA

A patient with type 2 diabetes needs add-on therapy but lives alone and has a history of severe hypoglycaemia. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — DPP-4 inhibitor or SGLT2 inhibitor subject to suitability

Medicines with lower hypoglycaemia risk may be preferable when severe hypoglycaemia is a particular concern. In this vignette, "DPP-4 inhibitor or SGLT2 inhibitor subject to suitability" is the safest single best answer. The other options are less appropriate because they miss the key clinical risk, conflict with UK medicines guidance, or delay needed review.

Reference: BNF; NICE CKS